Bovela

Authorised

This medicine is authorised for use in the European Union

bovine viral diarrhoea vaccine (modified live)

MedicineVeterinaryAuthorised

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

Application under evaluation
CVMP opinion
European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Bovela : EPAR - Summary for the public

English (EN) (81.94 kB - PDF)

Publicatiedatum: 17/02/2015 Laatst gewijzigd: 07/11/2024

Andere talen (25)

Product information

Bovela : EPAR - Product Information

English (EN) (81.49 kB - PDF)

Publicatiedatum: 17/02/2015 Laatst gewijzigd: 07/11/2024

Andere talen (25)

Bovela : EPAR - All Authorised presentations

English (EN) (81.94 kB - PDF)

Publicatiedatum: 17/02/2015 Laatst gewijzigd: 07/11/2024

Andere talen (25)

Product details

Name of medicine: Bovela
Active substance: modified live bovine viral diarrhoea virus type 1, non-cytopathic parent strain KE-9 and modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
International non-proprietary name (INN) or common name: bovine viral diarrhoea vaccine (modified live)

Authorisation details

EMA product number: EMEA/V/C/003703

Assessment history

Bovela : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (81.94 kB - PDF)

Publicatiedatum: 13/10/2016 Laatst gewijzigd: 07/11/2024

Bovela : EPAR - Public assessment report

Adopted

English (EN) (81.49 kB - PDF)

Publicatiedatum: 17/02/2015 Laatst gewijzigd: 07/11/2024

CVMP summary of positive opinion for Bovela

Adopted Reference Number: EMA/CVMP/575913/2014

English (EN) (75.18 kB - PDF)

Publicatiedatum: 10/10/2014 Laatst gewijzigd: 10/10/2014

News on Bovela

This page was last updated on 07/11/2024